Innovative Immunology Biotech Windward Bio Lists on Nasdaq
- Saturday, November 14, 2026, 2:11
- Business
- Add a comment
SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50…
About the Author
adminasapcorp has written 42626 stories on this site.